The intradermal injections market in South & Central America is expected to grow from US$ 213.89 million in 2021 to US$ 424.62 million by 2028. It is estimated to grow at a CAGR of 10.3% from 2021 to 2028.

Developed and Developing Countries Provide Significant Growth Opportunities to Market
Health systems in developing economies focus on introducing various advanced therapeutic, diagnostic, and aesthetic technologies into their service portfolios to be able to provide healthcare facilities with high efficiency. In developed countries, intradermal devices have received significant acceptance in vaccination and cosmetic procedures. In developing countries, although these devices are mainly used in vaccination, tuberculosis diagnosis, and aesthetic procedures, the market is currently in a nascent stage of development. Many developing countries are attractive destinations for medical tourism, especially for aesthetic procedures due to the lower costs of these procedures than developed countries. Health facilities, medical spas, and wellness centers in developing countries are increasingly offering a comprehensive range of inexpensive but high-quality medical-aesthetic procedures, which, eventually, triggers the demand for intradermal injections. The leading manufacturers of intradermal injections are developing ideal devices and collaborating with other players to improve the therapeutic efficacy of existing and new drugs. The rapid pace of urbanization, surging investments by healthcare providers in improving infrastructure, growing awareness among the population, and increasing availability of a range of advanced products and technologies are all contributing to the growth of this market.

Market Overview
The intradermal injections market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. In Brazil, the aging population is rising at a rapid pace, and the country faces regional and historical socioeconomic inequalities. It leads the South American pharmaceuticals market and medical device market, which can be mainly due to the huge population burden and a developed healthcare sector. With the high incidence of various communicable and noncommunicable diseases, the demand for intradermal injections has surged in the past few years. According to World Health Organization (WHO), the incidence rate of tuberculosis in Brazil was 45 per 100,000 population, with a detection rate of 78%, in 2020. Further, the growing cases of allergies, kidney diseases, cancer, etc., are likely to drive the adoption of medical devices, which will eventually drive the Brazil medical devices market during the forecast period.

South & Central America Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Intradermal Injections Market Segmentation

The South & Central America intradermal injections market is segmented on the basis of method, application, end user, and country. Based on method, the market is segmented into normal sized needle, short needle, and without needle. The normal sized needles segment registered the largest market share in 2021. The normal sized needles segment is further subsegmented into intradermal microinjections, microneedle arrays, and tattoo devices. The short needle segment is bifurcated into intradermal liquid jet injectors and ballistic intradermal injectors. In terms of application, the South & Central America intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held the largest market share in 2021. The South & Central America intradermal injections market, by end user, is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held the largest market share in 2021. Based on country, the market is segmented into Brazil, Argentina, and rest of South & Central America. Brazil dominated the market share in 2021.

BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; Eunsung Global; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd are the leading companies operating in intradermal injections market in the South & Central America region.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Intradermal Injections Market – By Method
1.3.2 SAM Intradermal Injections Market – By Application
1.3.3 SAM Intradermal Injections Market – By End User
1.3.4 SAM Intradermal Injections Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Intradermal Injections Market Landscape
4.1 Overview
4.2 SAM PEST ANALYSIS
4.3 EXPERT OPINIONS
5. SAM Intradermal Injections Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Intradermal Vaccination
5.1.2 Increasing Incidences of diseases
5.1.3 Rising Acceptance of Aesthetic Procedures
5.2 Key Market Restraints
5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections
5.3 Key Market Opportunities
5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries
5.4 Future Trends
5.4.1 Strategic Developments by Manufacturers
5.5 Impact Analysis of Drivers and Restraints
6. Intradermal Injections Market– SAM Analysis
6.1 SAM Intradermal Injections Market, By Country – Forecast and Analysis
7. SAM Intradermal Injections Market Revenue and Forecasts To 2028– By Method
7.1 Overview
7.2 SAM Intradermal Injections Market, By Method, 2021 & 2028 (%)
7.3 Normal-Sized Needles (MANTOUX)
7.3.1 Overview
7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)
7.4 Short Needles
7.4.1 Overview
7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.4.3 Intradermal Microinjection
7.4.3.1 Overview
7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.4.4 Microneedle Arrays
7.4.4.1 Overview
7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.4.5 Tattoo Devices
7.4.5.1 Overview
7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5 Without Needles
7.5.1 Overview
7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5.3 Intradermal Liquid Jet Injectors
7.5.3.1 Overview
7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5.4 Ballistic Intradermal Injectors
7.5.4.1 Overview
7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
8. SAM Intradermal Injections Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 SAM Intradermal Injections Market Share by Application – 2021 & 2028 (%)
8.3 Tuberculin Skin Testing
8.3.1 Overview
8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Allergy Testing
8.4.1 Overview
8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Local Aesthetics
8.5.1 Overview
8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)
8.6 OTHERS
8.6.1 Overview
8.6.2 Others Market Forecast and Analysis
9. SAM Intradermal Injections Market Analysis – End User
9.1 Overview
9.2 SAM Intradermal Injections Market, By End User, 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.6 OTHERS
9.6.1 Overview
9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
10. SAM Intradermal Injections Market Revenue and Forecasts To 2028 – Country Analysis
10.1 Overview
10.1.2 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
10.1.2.1 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.3 Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.1.3.1 Argentina: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.1.3.2 Argentina: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.1.4 Argentina: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.2.1.5 Argentina: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.3 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.2.3.1 Brazil: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.2.3.2 Brazil: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.2.4 Brazil: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.2.2.5 Brazil: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3 Rest of South and Central America: Intradermal Injections Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Rest of South and Central America: Intradermal Injections Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.3.3.1 Rest of South & Central America: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.3.3.2 Rest of South & Central America: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.3.4 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.1.2.3.5 Rest of South and Central America: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Developments
11.2.1 Overview
12. Company Profiles
12.1 BD
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 West Pharmaceutical Services, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Terumo Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 NanoPass
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pharmajet
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Idevax
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 EUNSUNG GLOBAL
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Crossject
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Cardinal Health Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Hindustan Syringes and Medical Devices Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 2. Argentina: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 3. Argentina: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 4. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 5. Argentina: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 7. Brazil: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 9. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 10. Brazil: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 12. Rest of South & Central America: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South & Central America: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 15. Rest of South and Central America: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Developments Done by Companies
Table 17. Glossary of Terms

LIST OF FIGURES

Figure 1. SAM Intradermal Injections Market Segmentation
Figure 2. SAM Intradermal Injections Market, By Country
Figure 3. SAM Intradermal Injections Market Overview
Figure 4. SAM Intradermal Injection Market, By Country
Figure 5. SAM Intradermal Injection Market, By Country
Figure 6. South and Central America PEST Analysis
Figure 7. EXPERT OPINIONS
Figure 8. SAM Intradermal Injection Market Impact Analysis of Drivers and Restraints
Figure 9. SAM Intradermal Injections Market – Revenue Forecast and Analysis – 2019- 2028
Figure 10. SAM Intradermal Injections Market, by Method, 2021 & 2028 (%)
Figure 11. SAM Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. SAM Short Needles: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. SAM Intradermal Microinjection: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. SAM Microneedle Arrays: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. SAM Tattoo Devices: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. SAM Without Needle: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. SAM Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. SAM Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. SAM Intradermal Injections Market Share by Application – 2021 & 2028 (%)
Figure 20. SAM Tuberculin Skin Test Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. SAM Allergy Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. SAM Local Aesthetic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. SAM Others Intradermal Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. SAM Intradermal Injections Market, by End User, 2021 & 2028 (%)
Figure 25. SAM Hospital: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. SAM Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. SAM Academic & Research Institutes: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. SAM Others: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. South and Central America Intradermal Injections Market, by Country- Revenue (2021) (US$ Million)
Figure 30. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
Figure 31. Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Rest of South and Central America: Intradermal Injections Market– Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America intradermal injections market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the South & Central America intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the intradermal injections market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – South and Central America Intradermal Injections Market

● BD.
● West Pharmaceutical Services, Inc.
● Terumo Corporation.
● Nanopass.
● PharmaJet.
● Idevax.
● Eunsung Global.
● Crossject.
● Cardinal Health Inc.
● Hindustan Syringes and Medical Devices Ltd.

At 10.3% CAGR, the South & Central America Intradermal Injection Market is speculated to be worth US$ 424.62 million by 2028, says The Insight Partners

According to the Insight Partners’ research, the South & Central America intradermal injection market was valued at US$ 213.89 million in 2021 and is expected to reach US$ 424.62 million by 2028, registering an annual growth rate of 10.3% from 2021 to 2028.Strategic developments by manufacturers and significant growth opportunities in developed as well as developing countries are the critical factors attributed to the market expansion.

Manufacturers in the Intradermal Injection market are adopting developmental strategies such as partnerships, collaborations, product launches, approvals, and mergers and acquisitions to sustain the competitive environment in the market. The companies are also undertaking the partnerships activities to strengthen their presence in the market and to boost the clinical research work for speeding up the development of various new candidates. The medical equipment manufacturers across the world are scaling up the production of their devices. Their involvement in various business developments and product innovations helps ensure the easy availability of the products in the regional markets. Moreover, the regulatory agencies are providing the required support through timely product approvals and permissions. Such strategic activities by manufacturers are expected to propel the growth of the intradermal injection market in coming years.

On the contrary, risks, complications, and dosing limitations associated with intradermal injections hurdles the growth of South & Central America intradermal injection market.

Based on method, the South & Central America intradermal injection market is segmented into normal sized needles, short needle, and without needle. The normal sized needles segment held 44.0%market share in 2021, amassing US$ 94.17 million. It is projected to garner US$ 180.19 million by 2028 to expand at 9.7% CAGR during 2021–2028. The normal sized needles segment is further subsegmented into intradermal microinjection,microneedle arrays,and tattoo devices. The short needle segment is further subsegmented intradermal liquid jet injectors and ballistic intradermal injectors. Based on application, the South & Central America intradermal injection market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held 34.0% market share in 2021, amassing US$ 72.64 million. It is projected to garner US$ 141.97 million by 2028 to expand at 10.0% CAGR during 2021–2028. Based on end user, the South & Central America intradermal injection market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held 42.1% market share in 2021, amassing US$ 90.08 million. It is projected to garner US$ 180.26 million by 2028 to expand at 10.4% CAGR during 2021–2028. Based on country, the South & Central America intradermal injection market has been categorized into Brazil, Argentina, and rest of SAM. Our regional analysis states that Brazil captured 57.8% market share in 2021. It was assessed at US$ 123.70 million in 2021 and is likely to hit US$ 251.73 million by 2028, exhibiting a CAGR of 10.7% during the forecast period. Key players profiles in the South & Central America intradermal injection market report are BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; Eunsung Global; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd among others.